dpp4 and glp 1 combination GLP-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Frontiers | Physiology and Pharmacology
Description
CURB YOUR APPETITE Tirzepatide effectively curbs hunger by regulating appetite signals, reducing cravings and promoting healthier eating habits

Advances in artificial intelligenceenabled products, device miniaturization, and robotics are just some of the areas that can potentially fuel significant improvements in patient treatment and quality of life

Furthermore, establishing an integrated collaborative system between endocrinology and anesthesiology, along with improving patient education on preoperative medication disclosure, is essential

This once-weekly treatment supports metabolic balance as part of a structured 3-month care plan

Always consult your healthcare provider for guidance

[DOI] [PubMed] [Google Scholar] Lpez de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D
